Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
Drug and Alcohol Review
|
October 6, 2005
The Australian study of HIV and injecting Drug Use. Part II: predicting exposure to hepatitis C and hepatitis B
S J Carruthers, W M Loxley, M Phillips, et al.
Endocrine Reviews
|
May 1, 1992
Dopamine agonists and pituitary tumor shrinkage
J S Bevan, J Webster, C W Burke, et al.
Pituitary
|
November 18, 2000
The therapeutic value of somatostatin and its analogues
S Farooqi, J S Bevan, M C Sheppard, et al.
British Journal of Clinical Pharmacology
|
February 1, 1985
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
P J Cowen, J S Bevan, B Gosden, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 13, 2012
Giant bilateral myelolipomas in a man with congenital adrenal hyperplasia
S C McGeoch, S Olson, Z H Krukowski, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1986
Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland
M M Esiri, J S Bevan, C W Burke, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 1, 1989
Bilateral renal cortical abscesses in a young woman with type 1 diabetes
J S Bevan, G J Griffiths, J D Williams, et al.
British Journal of Obstetrics and Gynaecology
|
December 1, 1989
Development of an invasive macroprolactinoma: a possible consequence of prolonged oestrogen replacement. Case report
J S Bevan, J Sussman, A Roberts, et al.
Clinical Endocrinology
|
August 1, 1987
Cushing's syndrome in pregnancy: the timing of definitive treatment
J S Bevan, M H Gough, M D Gillmer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1987
Pituitary apoplexy following isosorbide administration
J S Bevan, A M Oza, C W Burke, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
Drug and Alcohol Review
|
October 6, 2005
The Australian study of HIV and injecting Drug Use. Part II: predicting exposure to hepatitis C and hepatitis B
S J Carruthers, W M Loxley, M Phillips, et al.
Endocrine Reviews
|
May 1, 1992
Dopamine agonists and pituitary tumor shrinkage
J S Bevan, J Webster, C W Burke, et al.
Pituitary
|
November 18, 2000
The therapeutic value of somatostatin and its analogues
S Farooqi, J S Bevan, M C Sheppard, et al.
British Journal of Clinical Pharmacology
|
February 1, 1985
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
P J Cowen, J S Bevan, B Gosden, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 13, 2012
Giant bilateral myelolipomas in a man with congenital adrenal hyperplasia
S C McGeoch, S Olson, Z H Krukowski, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1986
Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland
M M Esiri, J S Bevan, C W Burke, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 1, 1989
Bilateral renal cortical abscesses in a young woman with type 1 diabetes
J S Bevan, G J Griffiths, J D Williams, et al.
British Journal of Obstetrics and Gynaecology
|
December 1, 1989
Development of an invasive macroprolactinoma: a possible consequence of prolonged oestrogen replacement. Case report
J S Bevan, J Sussman, A Roberts, et al.
Clinical Endocrinology
|
August 1, 1987
Cushing's syndrome in pregnancy: the timing of definitive treatment
J S Bevan, M H Gough, M D Gillmer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1987
Pituitary apoplexy following isosorbide administration
J S Bevan, A M Oza, C W Burke, et al.
Page
of 7